… FDA has granted Fast Track designation for sonelokimab for the treatment … development and expedite the review of drugs to treat … active axial spondyloarthritis (axSpA). The trial recruited 26 … non-radiographic axSpA and ankylosing spondylitis (AS), also known …

… safety and efficacy in any treatments developed from these findings. The … fundamentally alter the landscape of ankylosing spondylitis treatment. Ultimately, the study of … antigen presentation in ankylosing spondylitis severity. Exp Mol Med (2026). https:…

… avenues for improving the treatment of rheumatoid arthritis, a … the College of Pharmacy and Pharmaceutical Sciences and corresponding … approved by the FDA, a class of drugs that has … prescribed for conditions such as ankylosing spondylitis, Crohn’s disease, …

… the risk of developing OA.   Dietary … Treatment options include non-pharmacologic and pharmacologic methods.   Non pharmacologic … medications that are used to help treat …  Tofacitinib, Upadacitinib.   Ankylosing spondylitis: DMARDs including Methotrexate, …

… other biologics developed through recombinant DNA technology. Such drugs include therapies for … drug (DMARD) therapy has been inadequate. For the treatment of active ankylosing spondylitis in …

… antibody for the treatment of active ankylosing spondylitis (AS), has … for its use in treating moderate-to-severe psoriasis … ; the impact of pharmaceutical industry regulation and health … and bi-specific antibody drug development technology (Tetrabody) as the …

… protein-based drugs like … also enables development of monoclonal … Pharmaceuticals Ltd. received approval for the manufacture of Pertuzumab (drug … spondyloarthritis Ankylosing Spondylitis (AS) –Treatment of adults with severe active ankylosing spondylitis …

… CAG treatment is primarily based on acid-suppressing drugs. … early screening and development of effective pharmacological interventions would … Mounawra. Eur Rev Med Pharmacol Sci. 2015;19 … 47;cxcr6 in active ankylosing spondylitis. Curr Pharm Biotechnol …

… Drug Safety (MFDS) for three indications: psoriatic arthritis, ankylosing spondylitis … treatment of active psoriatic arthritis and ankylosing spondylitis … approved for treating active ankylosing spondylitis in … -radiographic axial spondyloarthritis in adults …

… as “Lynk Pharmaceuticals”), a clinical stage innovative drug development company focused … disease-modifying antirheumatic drugs (bDMARDs). The trial was led by … , being developed for the treatment of rheumatoid arthritis, ankylosing spondylitis, atopic …